Medication Competition Act

This bill would require the Secretary of Health and Human Services to determine the exclusivity periods that licensed biological products are eligible for and publish them on an existing public list. For the first interchangeable biological products, the exclusivity period would be listed within 30 days after its expiration date can be known, or within 30 days after the law takes effect for products licensed earlier. For original (reference) biological products licensed after the law takes effect, the exclusivity expiration date would be listed within 30 days of licensure. For reference products licensed before the law takes effect, the date would be listed within 2 years.

Full text and official record on Congress.gov

Sponsors

• Margaret Wood Hassan Democrat sponsor
• 1 cosponsors